SA48 Do 30-Day Out-of-Pocket Costs Influence Rifaximin Treatment Retention in Patients with Hepatic Encephalopathy?
Jun 1, 2023, 00:00
10.1016/j.jval.2023.03.2264
https://www.valueinhealthjournal.com/article/S1098-3015(23)02364-1/fulltext
Title :
SA48 Do 30-Day Out-of-Pocket Costs Influence Rifaximin Treatment Retention in Patients with Hepatic Encephalopathy?
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(23)02364-1&doi=10.1016/j.jval.2023.03.2264
First page :
Section Title :
Open access? :
No
Section Order :
11580